News FDA approves Roche potential haemophilia blockbuster Blood cancer drug Gazyva also gets new US use
News NICE backs funding for Pfizer, Novartis breast cancer drugs Pfizer had been giving drug free to NHS before decision
News Reimbursement remains biggest barrier to precision drugs Reimbursement more of a barrier than regulation
News NICE to play key role in UK drug fast-track scheme Former GSK CEO Sir Andrew Witty will oversee proceedings.
News Roche’s MS drug Ocrevus nears European market Roche's new multiple sclerosis drug Ocrevus (ocrelizumab) gained FDA approval in March, and since then has achieved remarkable revenues of half a billion dollars in the year to date.<
News NHS England chief hails ‘precedent setting’ outcomes deal wi... NHS England unveiled two new bespoke pricing deals with pharma companies yesterday, underlining its growing direct engagement with the industry.
News Ex-BioNTech execs launch 'AI-native' cancer company Two senior executives formerly at BioNTech have launched a new biotech, Bios Life, that they call "an AI-native cancer surveillance company."
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
